(2003; 58 pages)
WHO Drug Information Vol. 17, No. 4, 2003
RECOMMENDED INN LIST 50
INTERNATIONAL NONPROPRIETARY NAMES
FOR PHARMACEUTICAL SUBSTANCES
WORLD HEALTH ORGANIZATION • GENEVA
WHO DRUG INFORMATION
WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN). Its contents reflect, but do not present, WHO policies and activities and they embrace socioeconomic as well as technical matters.
The objective is to bring issues that are of primary concern to drug regulators and pharmaceutical manufacturers to the attention of a wide audience of health professionals and policy-makers concerned with the rational use of drugs. In effect, the journal seeks to relate regulatory activity to therapeutic practice. It also aims to provide an open forum for debate. Invited contributions will portray a variety of viewpoints on matters of general policy with the aim of stimulating discussion not only in these columns but wherever relevant decisions on this subject have to be taken.
WHO Drug Information is published 4 times a year and can be ordered from: Marketing and Dissemination, World Health Organization, 1211 Geneva 27, Switzerland.
Annual subscription rate: Sw.fr. 75. - surface mail (other rates available)
WHO Drug Information can be viewed at:
© World Health Organization 2002
Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. For rights of reproduction or translation, in part or in toto, application should be made to: Coordinator, Publications, World Health Organization, 1211 Geneva 27, Switzerland. The World Health Organization welcomes such applications.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
Authors alone are responsible for views expressed in signed contributions.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature which are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
WHO Drug Information
is now available at: